Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Capital Leases (2022 - 2023)

Historic Capital Leases for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to $1.4 million.

  • Lexeo Therapeutics' Capital Leases changed N/A to $1.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2022, which is N/A changed from last year.
  • As of Q3 2023, Lexeo Therapeutics' Capital Leases stood at $1.4 million.
  • Lexeo Therapeutics' 5-year Capital Leases high stood at $1.6 million for Q4 2022, and its period low was $1.4 million during Q3 2023.